Abiopharma

MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab

EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments

Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025

Insmed To Present at November and December 2025 Investor Conferences

Follow-up data for Kodiaks KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI)

Tevas Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS

Atea Pharmaceuticals to Host Third Quarter 2025 Financial Results and Business Update Conference Call on November 12, 2025

Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Apellis Pharmaceuticals to Present at the Stifel 2025 Healthcare Conference

Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing